(NYSE: ALC) Alcon's forecast annual revenue growth rate of 5.65% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.9%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.67%.
Alcon's revenue in 2025 is $10,185,000,000.On average, 26 Wall Street analysts forecast ALC's revenue for 2025 to be $5,150,232,000,000, with the lowest ALC revenue forecast at $4,955,716,800,000, and the highest ALC revenue forecast at $5,488,668,800,000. On average, 26 Wall Street analysts forecast ALC's revenue for 2026 to be $5,529,438,400,000, with the lowest ALC revenue forecast at $5,250,436,800,000, and the highest ALC revenue forecast at $5,897,347,200,000.
In 2027, ALC is forecast to generate $5,896,856,000,000 in revenue, with the lowest revenue forecast at $5,542,209,600,000 and the highest revenue forecast at $6,267,712,000,000.